Coloplast A/S Stock

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen 11:20:00 2024-06-10 am EDT 5-day change 1st Jan Change
833.6 DKK -0.86% Intraday chart for Coloplast A/S +3.30% +7.98%
Sales 2024 * 27.04B 3.9B Sales 2025 * 29.37B 4.23B Capitalization 189B 27.25B
Net income 2024 * 5.24B 756M Net income 2025 * 6.11B 881M EV / Sales 2024 * 7.71 x
Net Debt 2024 * 19.4B 2.8B Net Debt 2025 * 18.07B 2.61B EV / Sales 2025 * 7.05 x
P/E ratio 2024 *
36.2 x
P/E ratio 2025 *
31 x
Employees 15,930
Yield 2024 *
2.39%
Yield 2025 *
2.62%
Free-Float 58.44%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Coloplast A/S

1 day-0.74%
1 week+3.37%
Current month+1.14%
1 month-1.16%
3 months-13.57%
6 months+11.46%
Current year+8.06%
More quotes
1 week
810.60
Extreme 810.6
844.00
1 month
802.20
Extreme 802.2
881.00
Current year
757.80
Extreme 757.8
977.60
1 year
689.20
Extreme 689.2
977.60
3 years
689.20
Extreme 689.2
1 194.00
5 years
689.20
Extreme 689.2
1 194.00
10 years
413.10
Extreme 413.1
1 194.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 07-12-31
Director of Finance/CFO 52 05-12-31
Chairman 65 87-12-31
Members of the board TitleAgeSince
Director/Board Member 76 68-09-30
Director/Board Member 60 17-11-30
Chairman 65 87-12-31
More insiders
Date Price Change Volume
24-06-10 833.6 -0.86% 239 590
24-06-07 840.8 +1.35% 280,671
24-06-06 829.6 +1.39% 328,513
24-06-04 818.2 +1.39% 179,324
24-06-03 807 -2.16% 352,143

Delayed Quote Nasdaq Copenhagen, June 10, 2024 at 03:32 am EDT

More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
840.8 DKK
Average target price
907.3 DKK
Spread / Average Target
+7.90%
Consensus
  1. Stock Market
  2. Equities
  3. COLO B Stock